Discover 1,147 paid clinical trials in New Haven, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,147
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: New Haven CT, Hartford CT, Valhalla NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase3, Recruiting
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
for
Heart Failure, Diuretic Resistance
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT06209359
Phase1, Recruiting
Mechanisms of Diuretic Resistance in Heart Failure, Aim 2
for
Heart Failure
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05753059
Phase1, Recruiting
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
for
Stress Urinary Incontinence, Pelvic Organ Prolapse
Location: New Haven CT, Philadelphia PA, Pittsburgh PA, Durham NC
Sponsor: Ethicon, Inc.
Sex: Female
Age: 21+
Code: NCT04829175
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: New Haven CT, West Haven CT, Stony Brook NY, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06317649
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
for
Opioid Use Disorder
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 25 - 55
Code: NCT06160284
Phase1, Recruiting
The Recovery in Stroke Using PAP Study
for
Ischemic Stroke, Obstructive Sleep Apnea
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT04130503
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: New Haven CT, West Haven CT, Stony Brook NY, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase2, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: New Haven CT, North Haven CT, Derby CT, Guilford CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase2, Phase3, Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: New Haven CT, Trumbull CT, Hartford CT, Uniondale NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase2, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: New Haven CT, North Haven CT, Derby CT, Guilford CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase2, Phase3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study